Miramistin ion

DB19386InvestigationalSmall molecule

Miramistin ion is under investigation in clinical trial NCT05561816 (Efficacy and Safety of Dioxidin Versus Miramistin in Superficial Pyoderma).

Chemical structure of Miramistin ion
Formula / weight
C26H47N2O · 403.674 g/mol (avg)
Also known as
Benzenemethanaminium, n,n-dimethyl-n-(3-((1-oxotetradecyl)amino)propyl)- · Miramistin
Code names
BKH-14

Resolves to

Compound
UNII62S6VPY15UCAS91481-38-8ChEMBLCHEMBL4650936ChEBI758412PubChem72950
Structure
InChIKeyYEAYHNRJRKXWNV-UHFFFAOYSA-OSMILESCCCCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC1=CC=CC=C1
Targets
P18405SRD5A1

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Miramistin ion, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In